FIFTY PERCENT CURE RATE IN POOR RISK RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION

被引：0
|
作者：
Pohlreich, D. [1 ]
Vackova, B. [1 ]
Trnkova, M. [1 ]
Pytlik, R. [1 ]
Koren, J. [1 ]
Cieslar, P. [1 ]
Valkova, V. [1 ]
Gasova, Z. [2 ]
Kobylka, P. [2 ]
Trneny, M. [1 ]
机构：
[1] Charles Univ Prague, Gen Teaching Hosp, Dept Hematooncol 1, Prague, Czech Republic
[2] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-AB029
引用
收藏
页码：S449 / S450
页数：2
相关论文
共 50 条
  • [1] Autologous stem cell transplantation in refractory or relapsed Hodgkin lymphoma
    Afonso, S.
    Carvalhais, I.
    Carneiro, A.
    Araujo, J.
    Principe, F.
    Guimaraes, J. E.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S440 - S441
  • [2] Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma
    Fung, Henry C.
    Stiff, Patrick
    Schriber, Jeff
    Toor, Amir
    Smith, Eileen
    Rodriguez, Tulio
    Krishnan, Amrita
    Molina, Arturo
    Smith, David
    Ivers, Barbara
    Kogut, Neil
    Popplewell, Leslie
    Rodriguez, Roberto
    Somlo, George
    Forman, Stephen J.
    Nademanee, Auayporn
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (05) : 594 - 600
  • [3] A Cure Rate Survival Model after Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma Patients
    Mohseni, Navid
    Maboudi, Ali Akbar Khadem
    Baghestani, Ahmadreza
    Hajifathali, Abbas
    Saeedi, Anahita
    [J]. MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (03) : 427 - 437
  • [4] Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
    Domingo-Domenech, Eva
    Sureda, Anna
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [5] Treatment of relapsed Hodgkin lymphoma after autologous stem cell transplantation
    Illes Arpad
    Simon Zsofia
    Udvardy Miklos
    Magyari Ferenc
    Jona Adam
    Miltenyi Zsofia
    [J]. ORVOSI HETILAP, 2017, 158 (34) : 1338 - 1345
  • [6] Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
    Zhang, Chen
    Deng, Jili
    Xie, Yan
    Mi, Lan
    Liu, Weiping
    Wang, Xiaopei
    Zhao, Linjun
    Song, Yuqin
    Zhu, Jun
    [J]. CANCER MEDICINE, 2023, 12 (09): : 10351 - 10362
  • [7] Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma
    Broeckelmann, P. J.
    Mueller, H.
    Casasnovas, O.
    Hutchings, M.
    von Tresckow, B.
    Jurgens, M.
    McCall, S. J.
    Morschhauser, F.
    Fuchs, M.
    Borchmann, P.
    Moskowitz, C. H.
    Engert, A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (06) : 1352 - 1358
  • [8] Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study
    Deau, Benedicte
    Amorim, Sandy
    Perrot, Aurore
    Quittet, Philippe
    Cornillon, Jerome
    Chaoui, Driss
    Marolleau, Jean P.
    Oberic, Lucie
    Le Du, Katell
    Fornecker, Luc-Matthieu
    Tournilhac, Olivier
    Veillard, Anne S.
    Chaillol, Isabelle
    Robin, Marie
    Tamburini, Jerome
    Brice, Pauline
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (03) : 341 - 349
  • [9] Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation
    Kaloyannidis, Panayotis
    Hertzberg, Mark
    Webb, Kate
    Zomas, Athanasios
    Schrover, Rudolf
    Hurst, Michael
    Jacob, Ian
    Nikoglou, Thalia
    Connors, Joseph M.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 540 - 549
  • [10] AUTOLOGOUS STEM CELL TRANSPLANTATION FOR ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
    Crump, M. C.
    Villa, D.
    Kuruvilla, J.
    Kukreti, V
    Franke, N.
    Tsang, R.
    Keating, A.
    [J]. HAEMATOLOGICA, 2010, 95 : S25 - S25
12345